Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT05304663
What this trial is testing

Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression

Who this might be right for
Glioblastoma
Philogen S.p.A.
Large-scale testing (Phase 3)Looking for participantsNCT06496971
What this trial is testing

A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

Who this might be right for
Glioblastoma MultiformeGlioblastomaGlioblastoma Multiforme, Adult+5 more
NaviFUS Corporation 32
Very early researchEnded earlyNCT04869449
What this trial is testing

Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma Multiforme of Brain+1 more
Milton S. Hershey Medical Center 1
Early research (Phase 1)Study completedNCT01588769
What this trial is testing

A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients

Who this might be right for
Glioblastoma Multiforme
CytoVac A/S 23
Testing effectiveness (Phase 2)Study completedNCT04044937
What this trial is testing

Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms

Who this might be right for
Intracranial NeoplasmLow Grade GliomaRecurrent Glioblastoma+2 more
Thomas Hope 143
Not applicableAvailableNCT04566393
What this trial is testing

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Who this might be right for
Pancreatic CancerSmall Bowel CancerColorectal Cancer+18 more
xCures
Testing effectiveness (Phase 2)Study completedNCT01290692
What this trial is testing

Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

Who this might be right for
Grade IV GliomaGrade IV AstrocytomaGlioblastoma Multiforme
TVAX Biomedical 14
Early research (Phase 1)Ended earlyNCT00227032
What this trial is testing

Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
UNC Lineberger Comprehensive Cancer Center 10
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Early research (Phase 1)Not Yet RecruitingNCT06524063
What this trial is testing

Targeted Survivin DC Cell Injection for the Treatment of GBM

Who this might be right for
Glioblastoma
Beijing Tricision Biotherapeutics Inc 9
Testing effectiveness (Phase 2)Study completedNCT00004688
What this trial is testing

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaMixed Gliomas+2 more
Emory University 35
Testing effectiveness (Phase 2)Study completedNCT03388372
What this trial is testing

Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma

Who this might be right for
Glioblastoma
Biotech Pharmaceutical Co., Ltd. 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT04747145
What this trial is testing

Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma

Who this might be right for
Glioblastoma
Medical College of Wisconsin 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07439172
What this trial is testing

Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.

Who this might be right for
High Grade GliomasGlioblastomaAstrocytoma+1 more
The Cooper Health System 70
Testing effectiveness (Phase 2)Ended earlyNCT00238277
What this trial is testing

Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)UnknownNCT04004975
What this trial is testing

Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib

Who this might be right for
Recurrent Glioblastoma
Shandong Cancer Hospital and Institute 50
Testing effectiveness (Phase 2)Study completedNCT00846456
What this trial is testing

Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma

Who this might be right for
GlioblastomaBrain Tumor
Oslo University Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06991101
What this trial is testing

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaBrain CancerGlioblastoma Multiforme+4 more
Baptist Health South Florida 190
Testing effectiveness (Phase 2)Study completedNCT00944801
What this trial is testing

Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
University of Regensburg 63
Early research (Phase 1)WithdrawnNCT00734864
What this trial is testing

Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma

Who this might be right for
Glioblastoma MultiformeGliosarcomaAnaplastic Astrocytoma+2 more
Annick Desjardins
Next Page